Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker

JOURNAL OF INVESTIGATIVE DERMATOLOGY

ELSEVIER SCIENCE INC

1. National Cancer Institute Specialized Programs of Research Excellence grant [P50 CA093459]
2. University of Texas M. D. Anderson Cancer Center Support Grant [P30 CA016672]